High Prevalence of Alcohol Use Disorders in Eczema

This article originally appeared here.
Share this content:
High Prevalence of Alcohol Use Disorders in Eczema
High Prevalence of Alcohol Use Disorders in Eczema

TUESDAY, April 4, 2017 (HealthDay News) -- Patients with eczema have a high prevalence of alcohol use disorders, according to a study published online March 27 in the British Journal of Dermatology.

K. Al-Jefri, from the Newcastle Hospitals NHS Trust in the United Kingdom, and colleagues conducted an observational cross-sectional study involving 609 patients in five groups: psoriasis, eczema, cutaneous lupus, other inflammatory disorders, and a reference population with skin lesions. They examined the proportion of patients in each group with an alcohol use disorder (AUD).

The researchers found that the prevalence of AUD was 30.6 percent for the psoriasis group, 33.3 percent for the eczema group, 12.3 percent for the cutaneous lupus group, 21.8 percent for the other inflammatory disease group, and 14.3 percent for the non-inflammatory disease group. Compared with the non-inflammatory disease group, the odds ratios for AUD were 1.65 (95 percent confidence interval, 0.86 to 3.17) for psoriasis, 2 (95 percent confidence interval, 1.03 to 3.85) for eczema, 1.03 (95 percent confidence interval, 0.39 to 2.71) for lupus, and 1.32 (95 percent confidence interval, 0.68 to 2.56) for other inflammatory disease, after adjustment for age and gender. Adjustment for Dermatology Life Quality Index further reduced the odds ratios.

"Patients with eczema attending a single site hospital clinic have been shown to have high levels of alcohol use disorders of a similar level to patients with psoriasis and higher than patients with non-inflammatory skin diseases," the authors write.

Abstract
Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »


Sign up for myCME e-newsletters


Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions

More in Home

Post-C-Section Cephalexin, Metronidazole Cuts SSI Rate

Post-C-Section Cephalexin, Metronidazole Cuts SSI Rate

Post-op course reduces rate of surgical site infection within 30 days of C-section among obese women

Multicomponent Intervention Linked to Greater Drop in BP

Multicomponent Intervention Linked to Greater Drop in BP

Intervention beneficial over 18 months for low-income adults in Argentina with uncontrolled HTN

Total of 0.21 Years Lost Due to Opioid-Related Poisoning Deaths

Total of 0.21 Years Lost Due to Opioid-Related ...

Drug-related poisoning deaths up from 2000 to 2015, with most of the increase due to opioid deaths

is free, fast, and customized just for you!

Already a member?

Sign In Now »